Fact of the day 🔍
According to a study by IQVIA, decentralised clinical trials (DCTs) can realise a 78% reduction in recruiting time, measured by time from first patient in to last patient in.
Triall offers a range of integrated DCT tools that streamline and promote patient engagement throughout your clinical study.
Source: bit.ly/3BxPXev
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1637752241418383361?s=20
#blockchainforhealth #TRL
According to a study by IQVIA, decentralised clinical trials (DCTs) can realise a 78% reduction in recruiting time, measured by time from first patient in to last patient in.
Triall offers a range of integrated DCT tools that streamline and promote patient engagement throughout your clinical study.
Source: bit.ly/3BxPXev
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1637752241418383361?s=20
#blockchainforhealth #TRL
Triall at BIO-Europe🇨🇭
Over the past 3 days, Triall team members Hadil and Ray attended #BIOEuropeSpring in Basel, Switzerland.
BIO-Europe is one of the largest partnering events for the European biopharma industry.
The event proved to be a great venue for partnering discussions as we managed to sit down with over 20 forward-thinking clinical CROs and potential strategic partners.
We can look back on many productive meetings and like to thank EBD Group for setting up this professional event!
🗣️ Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1638897389904752640?s=20
#blockchainforhealth #TRL
Over the past 3 days, Triall team members Hadil and Ray attended #BIOEuropeSpring in Basel, Switzerland.
BIO-Europe is one of the largest partnering events for the European biopharma industry.
The event proved to be a great venue for partnering discussions as we managed to sit down with over 20 forward-thinking clinical CROs and potential strategic partners.
We can look back on many productive meetings and like to thank EBD Group for setting up this professional event!
🗣️ Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1638897389904752640?s=20
#blockchainforhealth #TRL
Announcing the next community AMA 📺💬
Curious about the latest developments at Triall?
On March 30 at 12:00 UTC, Triall will host its 13th community AMA on YouTube, answering live and pre-submitted questions from the TRL community.
🎙 AMA Guests
- Hadil Es-Sbai, Chief Executive Officer
- Dr. Arno Bisschop, Chief Medical Officer
- Raymond van der Waal, Head of Strategic Partnerships
📬 AMA Questions
Submit your questions here: bit.ly/TRLvidAMA13
The 5 best questions get $50 in TRL tokens💰
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1640310617545273344?s=20
#blockchainforhealth #TRL
Curious about the latest developments at Triall?
On March 30 at 12:00 UTC, Triall will host its 13th community AMA on YouTube, answering live and pre-submitted questions from the TRL community.
🎙 AMA Guests
- Hadil Es-Sbai, Chief Executive Officer
- Dr. Arno Bisschop, Chief Medical Officer
- Raymond van der Waal, Head of Strategic Partnerships
📬 AMA Questions
Submit your questions here: bit.ly/TRLvidAMA13
The 5 best questions get $50 in TRL tokens💰
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1640310617545273344?s=20
#blockchainforhealth #TRL
New staking pool is closing soon 💎
Interested in staking your $TRL tokens? Our staking pool is closing in 1 week from now.
The BSC Holder 7 (8% APR) pool is available on BSC and runs for 100 days.
New to $TRL staking?
(1) Whitelist yourself at bit.ly/TRLwhitelist
(2) Read the guide at bit.ly/stakingTRL
Staking powered by Ferrum Network.
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1640651606290051072?s=20
#blockchainforhealth #TRL
Interested in staking your $TRL tokens? Our staking pool is closing in 1 week from now.
The BSC Holder 7 (8% APR) pool is available on BSC and runs for 100 days.
New to $TRL staking?
(1) Whitelist yourself at bit.ly/TRLwhitelist
(2) Read the guide at bit.ly/stakingTRL
Staking powered by Ferrum Network.
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1640651606290051072?s=20
#blockchainforhealth #TRL
Triall at Innovation for Health 2023 🇳🇱
Next week, Triall team members Ray and Arno will be attending the 10th edition of Innovation for Health (#I4H) in Rotterdam.
I4H brings together over 900 Life Sciences innovators, entrepreneurs, thought leaders, and other key partners to discuss the future of healthcare.
The theme for this years conference builds upon previous editions and will focus on the topic of digital transformation.
Want to see us on stage? Triall will be participating in the I4H startup pitching competition to showcase our company and attract potential strategic partners and investors.
👉 More info at hyphenprojects.nl/i4h/
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1641397843347775491?s=20
#blockchainforhealth #TRL #events #startups
Next week, Triall team members Ray and Arno will be attending the 10th edition of Innovation for Health (#I4H) in Rotterdam.
I4H brings together over 900 Life Sciences innovators, entrepreneurs, thought leaders, and other key partners to discuss the future of healthcare.
The theme for this years conference builds upon previous editions and will focus on the topic of digital transformation.
Want to see us on stage? Triall will be participating in the I4H startup pitching competition to showcase our company and attract potential strategic partners and investors.
👉 More info at hyphenprojects.nl/i4h/
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1641397843347775491?s=20
#blockchainforhealth #TRL #events #startups
And we’re live once again! 🚨📺💬
Tune in to this month’s live #community #AMA 👇
https://www.youtube.com/live/Trmr_M1BCO4?feature=share
Tune in to this month’s live #community #AMA 👇
https://www.youtube.com/live/Trmr_M1BCO4?feature=share
YouTube
Triall community AMA #13
In the Triall community AMA, members of the core Triall team answer live and pre-submitted questions from the audience covering everything from our product to underlying technologies, industry trends, market dynamics, and our utility token TRL.
_________…
_________…
Triall Insights 🔍
According to Tufts CSDD, 119 protocol deviations occur on average in a typical Phase 3 clinical trial.
These protocol deviations are the top reason for clinical trial enforcement actions by regulators such as the FDA.
Triall offers an end-to-end eClinical platform that harmonises and enforces protocol compliance across all participating research sites.
Source: https://bit.ly/3xV0YVc
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1642845370836213760?s=20
#blockchainforhealth #TRL
According to Tufts CSDD, 119 protocol deviations occur on average in a typical Phase 3 clinical trial.
These protocol deviations are the top reason for clinical trial enforcement actions by regulators such as the FDA.
Triall offers an end-to-end eClinical platform that harmonises and enforces protocol compliance across all participating research sites.
Source: https://bit.ly/3xV0YVc
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1642845370836213760?s=20
#blockchainforhealth #TRL
Triall at Innovation for Health 🇳🇱
Last week, Triall team members Ray and Arno attended the 10th edition of Innovation for Health (#I4H), the largest Life Sciences innovation conference in The Netherlands.
As part of I4H’s sister-event Global Investor Forum, Triall participated in a startup pitching competition, showcasing its product roadmap to potential strategic partners and investors.
We very much enjoyed sharing the stage with other Life Sciences innovators and like to thank Hyphen Projects for hosting this energising event 🔥
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1646122966562885632?s=20
#blockchainforhealth #TRL
Last week, Triall team members Ray and Arno attended the 10th edition of Innovation for Health (#I4H), the largest Life Sciences innovation conference in The Netherlands.
As part of I4H’s sister-event Global Investor Forum, Triall participated in a startup pitching competition, showcasing its product roadmap to potential strategic partners and investors.
We very much enjoyed sharing the stage with other Life Sciences innovators and like to thank Hyphen Projects for hosting this energising event 🔥
🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1646122966562885632?s=20
#blockchainforhealth #TRL
Announcing the AMA winners 🏆📺💬
We’re excited to announce the AMA winners of our 13th monthly community AMA live on YouTube.
AMA winner list
@Algojali
@Pandalucu66
@peterson682
@Cassliu
@KangKung70
How do I redeem my reward?
Please contact @rxvdwaal to share your BEP-20 address.
Missed the live session?
Check out the full recording: youtube.com/live/Trmr_M1BCO4
When is the next AMA?
Our next community AMA will be hosted by the end of this month (date to be announced).
#blockchainforhealth #TRL
We’re excited to announce the AMA winners of our 13th monthly community AMA live on YouTube.
AMA winner list
@Algojali
@Pandalucu66
@peterson682
@Cassliu
@KangKung70
How do I redeem my reward?
Please contact @rxvdwaal to share your BEP-20 address.
Missed the live session?
Check out the full recording: youtube.com/live/Trmr_M1BCO4
When is the next AMA?
Our next community AMA will be hosted by the end of this month (date to be announced).
#blockchainforhealth #TRL
Triall Insights 🔍
Gartner predicts that by 2025, 60% of large organisations will use at least one privacy-enhancing computation (PEC) technique in analytics, business intelligence, and/or cloud computing.
Unlike common data-at-rest security controls, PEC protects data in use, thereby enabling data processing in untrusted and multi-party data sharing environments.
Triall is applying multiple PEC techniques to enable new decentralised and privacy-preserving methods of clinical trial data exchange.
Source: bit.ly/3UDZoBa
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1647926547838320640?s=20
#blockchainforhealth #TRL
Gartner predicts that by 2025, 60% of large organisations will use at least one privacy-enhancing computation (PEC) technique in analytics, business intelligence, and/or cloud computing.
Unlike common data-at-rest security controls, PEC protects data in use, thereby enabling data processing in untrusted and multi-party data sharing environments.
Triall is applying multiple PEC techniques to enable new decentralised and privacy-preserving methods of clinical trial data exchange.
Source: bit.ly/3UDZoBa
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1647926547838320640?s=20
#blockchainforhealth #TRL
Triall Insights 🔍
9 out of 10 clinical trials worldwide can’t recruit enough people within their target timeframes.
Some trials fail altogether for lack of enough participants.
Triall aims to make participating in clinical research more attractive by devising novel ways to empower, compensate, and incentivise patients.
Source: bit.ly/43VttQX
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1650459429001740288?s=20
#blockchainforhealth #TRL
9 out of 10 clinical trials worldwide can’t recruit enough people within their target timeframes.
Some trials fail altogether for lack of enough participants.
Triall aims to make participating in clinical research more attractive by devising novel ways to empower, compensate, and incentivise patients.
Source: bit.ly/43VttQX
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1650459429001740288?s=20
#blockchainforhealth #TRL
Announcing the MayMilestones series 🏆
Dear Triallians,
We’re thrilled to announce the #MayMilestones series, a collection of high-impact updates on our software platform, technology roadmap, and utility token $TRL.
Keep an eye on our channels and follow us on this transformative journey!
MayMilestones calendar
✅ W18 May 1-May 7: Roadmap
✅ W19 May 8-May 14: DIA
✅ W20 May 15-May 21: Team
✅ W21 May 22-May 28: Prototype
☑️ W22 May 29-June 4: TBA
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1651181983622475778?s=20
#blockchainforhealth #TRL
Dear Triallians,
We’re thrilled to announce the #MayMilestones series, a collection of high-impact updates on our software platform, technology roadmap, and utility token $TRL.
Keep an eye on our channels and follow us on this transformative journey!
MayMilestones calendar
✅ W18 May 1-May 7: Roadmap
✅ W19 May 8-May 14: DIA
✅ W20 May 15-May 21: Team
✅ W21 May 22-May 28: Prototype
☑️ W22 May 29-June 4: TBA
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1651181983622475778?s=20
#blockchainforhealth #TRL
Triall Insights 🔍
According to Tufts CSDD, the typical Phase III clinical trial conducted during 2016-2021 had an average of 25.8 endpoints.
This number is 37% higher compared to 2015, signalling a sharp increase in clinical trial complexity.
Triall is building data-driven solutions that help clinical research professionals design and operate complex clinical trial studies.
Source: csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1653020244980518914?s=20
#blockchainforhealth #TRL
According to Tufts CSDD, the typical Phase III clinical trial conducted during 2016-2021 had an average of 25.8 endpoints.
This number is 37% higher compared to 2015, signalling a sharp increase in clinical trial complexity.
Triall is building data-driven solutions that help clinical research professionals design and operate complex clinical trial studies.
Source: csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1653020244980518914?s=20
#blockchainforhealth #TRL
MayMilestones: Roadmap update 🚀
We're excited to present an update on our product roadmap, focusing on the build and market introduction of the Clinical Insights Exchange (CIX).
The CIX is a Web3 federated data marketplace where biopharma companies, clinicians, and patients can exchange research data & insights without having to share underlying data resources
It builds upon 5 years of R&D, including the development of blockchain and Self-Sovereign Identity (SSI) APIs, SDKs, infra, and components.
This update marks Phase 3 of our long-term roadmap and entails the further integration of $TRL, which will be used as a primary means of access, benefit-sharing, and reimbursement.
👉 Check out the roadmap: bit.ly/TRLroadmap3
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1654089098695458817?s=20
#blockchainforhealth #TRL #MayMilestones
We're excited to present an update on our product roadmap, focusing on the build and market introduction of the Clinical Insights Exchange (CIX).
The CIX is a Web3 federated data marketplace where biopharma companies, clinicians, and patients can exchange research data & insights without having to share underlying data resources
It builds upon 5 years of R&D, including the development of blockchain and Self-Sovereign Identity (SSI) APIs, SDKs, infra, and components.
This update marks Phase 3 of our long-term roadmap and entails the further integration of $TRL, which will be used as a primary means of access, benefit-sharing, and reimbursement.
👉 Check out the roadmap: bit.ly/TRLroadmap3
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1654089098695458817?s=20
#blockchainforhealth #TRL #MayMilestones
Triall Insights 🔍
According to Tufts CSDD, a typical Phase III clinical trial now includes 13 countries on average.
This is a 39% increase compared to 2015, highlighting the further globalisation of clinical research.
Triall offers purpose-built eClinical solutions that can be tailored to country-specific needs and requirements.
Source: csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1655531333563691010?s=20
#blockchainforhealth #TRL
According to Tufts CSDD, a typical Phase III clinical trial now includes 13 countries on average.
This is a 39% increase compared to 2015, highlighting the further globalisation of clinical research.
Triall offers purpose-built eClinical solutions that can be tailored to country-specific needs and requirements.
Source: csdd.tufts.edu/impact-reports
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1655531333563691010?s=20
#blockchainforhealth #TRL
MayMilestones: Triall invited to speak at DIA 2023 in Boston ✈️
Triall CEO Hadil has been invited to host two presentations at #DIA2023, the world’s premier biopharma event.
DIA 2023 is a 5-day event that attracts industry professionals, regulators, and patient representatives from across the globe to network, problem-solve, and discuss key challenges.
The event therefore offers a unique opportunity for us to present and validate our solutions and decentralised technology stack with a global audience of experts.
Triall presentations:
📅 Blockchain-Based Technologies for Clinical Research: Distinguishing Myth from Reality
📅 The True Decentralization of Clinical Trials: Benefits and Drawbacks of Blockchain Technology
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1656626801559437312?s=20
#blockchainforhealth #TRL #MayMilestones
Triall CEO Hadil has been invited to host two presentations at #DIA2023, the world’s premier biopharma event.
DIA 2023 is a 5-day event that attracts industry professionals, regulators, and patient representatives from across the globe to network, problem-solve, and discuss key challenges.
The event therefore offers a unique opportunity for us to present and validate our solutions and decentralised technology stack with a global audience of experts.
Triall presentations:
📅 Blockchain-Based Technologies for Clinical Research: Distinguishing Myth from Reality
📅 The True Decentralization of Clinical Trials: Benefits and Drawbacks of Blockchain Technology
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1656626801559437312?s=20
#blockchainforhealth #TRL #MayMilestones
Triall Insights 🔍
According to the IQVIA Institute, US venture capital deal value in biopharma reached $42B in 2022.
Deal activity and investment flows in the US accelerated in the preceding 3 years as interest in Life Sciences intensified, with more than 2,000 deals occurring across 2022.
Source: iqvia.com/insights/the-iqvia-institute/reports/global-trends-in-r-and-d-2023
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1658408678045745152?s=20
#blockchainforhealth #TRL
According to the IQVIA Institute, US venture capital deal value in biopharma reached $42B in 2022.
Deal activity and investment flows in the US accelerated in the preceding 3 years as interest in Life Sciences intensified, with more than 2,000 deals occurring across 2022.
Source: iqvia.com/insights/the-iqvia-institute/reports/global-trends-in-r-and-d-2023
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1658408678045745152?s=20
#blockchainforhealth #TRL
MayMilestones: Team expansion 🤝
Triall welcomes Arjan Groen as its newest addition to the team.
Arjan is an AI developer and data scientist who will support Triall in the design, development, and validation of advanced (AI-enabled) analytics capabilities.
He brings a unique combination of expertise with a strong background in Machine Learning, data science, and business intelligence (BI) applied to healthcare.
Arjan is a published author on computer-aided diagnosis and has previously developed Deep Learning models for radiology as well as various BI capabilities.
Arjan on Triall: “There is enormous unfulfilled potential for Data & AI in the health and life science sector. All that’s lacking is a secure and privacy-friendly way to exchange data & insights. Triall is solving this problem.”
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1658808952170192903?s=20
#blockchainforhealth #TRL #MayMilestones
Triall welcomes Arjan Groen as its newest addition to the team.
Arjan is an AI developer and data scientist who will support Triall in the design, development, and validation of advanced (AI-enabled) analytics capabilities.
He brings a unique combination of expertise with a strong background in Machine Learning, data science, and business intelligence (BI) applied to healthcare.
Arjan is a published author on computer-aided diagnosis and has previously developed Deep Learning models for radiology as well as various BI capabilities.
Arjan on Triall: “There is enormous unfulfilled potential for Data & AI in the health and life science sector. All that’s lacking is a secure and privacy-friendly way to exchange data & insights. Triall is solving this problem.”
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1658808952170192903?s=20
#blockchainforhealth #TRL #MayMilestones
Triall Insights 🔍
According to a BMJ study that analysed 225 Phase 3 clinical trials, the median estimated cost per patient for a study amounted to $42,413.
Costs were highest for drugs that required comparison with an already approved & effective drug and lowest for those where the FDA waived the requirements for a control group.
Source: bmjopen.bmj.com/content/10/6/e038863.full
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1660605909431713792?s=20
#blockchainforhealth #TRL
According to a BMJ study that analysed 225 Phase 3 clinical trials, the median estimated cost per patient for a study amounted to $42,413.
Costs were highest for drugs that required comparison with an already approved & effective drug and lowest for those where the FDA waived the requirements for a control group.
Source: bmjopen.bmj.com/content/10/6/e038863.full
⚡️ Trade $TRL at bit.ly/tradeTRL
🗣 Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1660605909431713792?s=20
#blockchainforhealth #TRL